GRI Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 8106.8%.

Top 14 shareholders own 5.07% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.45%	UBS Asset Management AG	71,647	US$52.5k	299%	no data
1.1%	Susquehanna International Group, LLP, Asset Management Arm	32,272	US$23.7k	0%	no data
0.48%	Hudson River Trading LLC, Asset Management Arm	13,965	US$10.2k	0%	no data
0.4%	Geode Capital Management, LLC	11,847	US$8.7k	7,210%	no data
0.15%	Tower Research Capital Europe Limited	4,464	US$3.3k	1,350%	no data
0.14%	W. Hertz	4,235	US$3.1k	1,200%	no data
0.12%	BlackRock, Inc.	3,596	US$2.6k	-16.4%	no data
0.077%	Tep Biotech, Llc	2,252	US$1.7k	0%	no data
0.065%	Albert Agro	1,891	US$1.4k	-0.05%	no data
0.065%	Vipin Kumar Chaturvedi	1,891	US$1.4k	-0.05%	no data
0.0069%	The Vanguard Group, Inc.	203	US$148.7	0%	no data
0.00079%	Bank of America Corporation, Asset Management Arm	23	US$17.0	1,050%	no data
0.0001%	David Baker	3	US$2.1	200%	no data
0.00007%	Leanne Kelly	2	US$1.5	100%	no data